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Introduction: Recent evidence has implicated perituberal, MRI-normal brain tissue as a possible source of seizures
in tuberous sclerosis complex (TSC). Data on aberrant structural features in this area that may predispose to the
initiation or progression of seizures are very limited. We used immunohistochemistry and confocal microscopy to
compare epileptogenic, perituberal, MRI-normal tissue with cortical tubers.
Results: In every sample of epileptogenic, perituberal tissue, we found many abnormal cell types, including giant cells
and cytomegalic neurons. The majority of giant cells were surrounded by morphologically abnormal astrocytes with long
processes typical of interlaminar astrocytes. Perituberal giant cells and astrocytes together formed characteristic
“microtubers”. A parallel analysis of tubers showed that many contained astrocytes with features of both protoplasmic
and gliotic cells.
Conclusions: Microtubers represent a novel pathognomonic finding in TSC and may represent an elementary unit of
cortical tubers. Microtubers and cytomegalic neurons in perituberal parenchyma may serve as the source of seizures in
TSC and provide potential targets for therapeutic and surgical interventions in TSC.
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Cortical tubers are a hallmark of the brain pathology and a
main source of epileptic activity in patients with tuberous
sclerosis complex (TSC) [1]. TSC is an autosomal dominant
disorder caused by mutations in TSC1 or TSC2. Loss of
function of these genes leads to activation of the mTOR
cascade, which is critical for cellular growth and develop-
ment of numerous organ systems [2-4].
Tubers are a type of cerebral cortical malformation that
are characterized by a prominent irregularity in neocortical
cytoarchitecture. Tubers are composed of abnormal cells in-
cluding giant cells, dysplastic/cytomegalic neurons, and ab-
errant tuber astrocytes. Although tubers are generally
thought to be a source of ictal activity in TSC epilepsy, seiz-
ure initiation from perituberal tissue has been documented* Correspondence: gm317@columbia.edu
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unless otherwise stated.in several reports suggesting other mechanisms for epilepto-
genesis than the effects of tubers on network excitability
[5-9].
Perituberal “MRI-normal” tissue is often resected during
TSC epilepsy surgery as part of the epileptogenic zone, and
is usually considered to be a structurally “normal” area of
brain adjoining a nearby epileptogenic cortical tuber. For
example, Wang et al. [10] reported an epileptogenic focus
in a TSC patient who displayed no cortical tubers by
MRI. However, analysis of gliosis in TSC revealed peritub-
eral collections of giant cells and gliotic astrocytes that we
designated “microtubers” [11]. A recent autopsy study also
detected considerable TSC pathology outside of cortical tu-
bers, including lamination abnormalities, heterotopias, and
giant cells [12]. These authors also designated pathological
clusters of giant cells and dystrophic neurons outside of tu-
bers as “microtubers.”
In this study, we have examined MRI-normal, perituberal
tissues in patients who had surgical resections for epilepsy.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the epileptogenic zone in many of these patients. In every
sample of epileptogenic, perituberal tissue, we found abnor-
mal cellular pathology, including cytomegalic neurons,
giant cells, and gliotic astrocytes. Most of the perituberal
giant cells or groups of giant cells in the cortex were
surrounded by gliotic astrocytes, together forming “micro-
tubers”. We fully describe the features of perituberal
“microtubers” and focus on the importance of pathological
gliotic astrocytes together with giant cells as the fundamen-
tal elements of these potentially epileptogenic structures.
Materials and Methods
Tissue
Specimens including cortical tubers (n = 16) and MRI nor-
mal perituberal tissue (n = 10) were obtained from TSC
patients with medically refractory epilepsy who were under-
going epilepsy surgical resection. In one case, hippocampus
with MRI normal architecture was resected as the epilepto-
genic area together with adjoining cortical tubers. The
mean age of the 16 patients was 9.8 ± 1.5 years (range: 2.5
– 23 years), with 9 females and 7 males. The epileptogeni-
city of the resected tubers and perituberal tissue was
established during invasive subdural intracranial monitor-
ing of patients, as previously described [9]. Perituberal
tissue did not show any abnormalities on detailed pre-
operative MRI examination using imaging protocols
designed to maximize preoperative detection of malforma-
tions of cortical development. The location of the tuberal
tissue and MRI normal perituberal tissue was confirmed
intraoperatively by gross visual inspection, as well as by
frameless stereotactic intraoperative MRI based surgical
navigation. All patient protocols were approved by the In-
stitutional Review Boards of Columbia University Medical
Center and New York University Medical Center.
Histology and immunohistochemistry
Specimens were fixed in 4% paraformaldehyde in PBS
for 14–18 h (4°C). 40 μm sections were prepared with a
vibratome (Leica VT1000S) and stored in cryoprotectant
solution at -20°C. Standard procedure for Nissl staining
with cresyl violet was used for routine analysis of tissue.
Antibodies
Primary antibodies used in the study are shown in Table 1.
Secondary antibodies include: conjugated to fluoro-
phores: anti-mouse Alexa Fluor 488, 594, and 633; anti-
chicken Alexa Fluor 594, 633; anti-rabbit Alexa Fluor
594; anti-goat Alexa Fluor 594, 633; anti-guinea pig
Alexa Fluor 594, 633, all from goat or donkey (1:300,
Molecular Probes, Eugene, OR).
Antigen retrieval procedure was performed with Anti-
gen Unmasking Solution (Vector Laboratories, Inc., Bur-
lingame, CA) by boiling for 40 sec in a microwave.For light microscopy sections were pretreated in 3%
H2O2 in methanol (30 min, at room temperature [RT])
and after blocking in 10% donkey serum (30 min, RT) in-
cubated overnight (4°C) with primary antibodies. After
washing sections were incubated with biotinylated second-
ary antibodies (1:1000, 1 hr, RT) and then, after washing,
with avidin–biotin-peroxidase complex (ABC, Vector
Lab.) (1 hr, RT). Peroxidase activity was visualized with
0.03% DAB (Sigma) with 0.005% H2O2 in 0.05 M Tris buf-
fer. Sections were transferred to glass slides, dehydrated in
a graded ethanol series and mounted in DPX (Sigma).
For double- and triple-immunofluorescence, after
blocking with 10% normal goat (or donkey) serum
(30 min, RT), free-floating sections were incubated in a
mixture of primary antibodies raised in different species
for overnight (4°C). For visualization, Alexa Fluor-
conjugated secondary antibodies were used for 1 h at
RT. Fluorescent Nissl reagent (NeuroTrace 640/660
deep-red, 1:150, Molecular Probes) was applied simul-
taneously with secondary antibodies in cases of double-
immunostaining for visualization of general histological
structure.
Blocking serum, primary, secondary antibodies, and fluor-
escent Nissl reagent were applied in 0.2 % Triton X-100 in
PBS. Sections for fluorescent microscopy were mounted on
slides in Vectashield (Vector Lab). To control the specifi-
city of immunostaining, primary antibodies were omitted
and substituted with appropriate normal serum. Slides
were viewed using a confocal microscope (Bio-Rad Radi-
ance 2000, Nikon E800).
Quantitative immunohistochemical analysis
We determined the size of microtubers using the diam-
eter of the area occupied by astrocytes with high levels
of GFAP or vimentin in the images (merged from the
stacks of adjacent 6 images [1024 × 1024 pixel reso-
lution, observed area 606 × 606 μm] captured at a dis-
tance of 1 μm from each other) obtained with a confocal
microscope. In cases of oval-shaped microtubers, the
longest diameter was measured. The border of microtu-
bers was considered as the point at which the immuno-
staining of GFAP/vimentin decreased significantly. The
long processes of astrocytes were excluded in the deter-
mination of borders. Furthermore, since most tubers
contained astrocytes that did not stain with anti-GS anti-
bodies, a double immunostaining for GS and either
GFAP or vimentin showed the border clearly.
The numbers of (1) giant cells (detected with GS and
p-S6 immunostaining), (2) p-S6+, p44/42+, and SPARC+
astrocytes in microtubers (detected in double immuno-
stained sections for p-S6/p44/42/SPARC and GFAP), (3)
CD68- and IBA1-immunolabeled microglial cells (in micro-
tubers in double immunostaining with GFAP, and in tuber
border area in double immunostaining with GS) were
Table 1 Primary antibodies used for immunohistochemistry
Glial fibrillary acidic protein (GFAP) Monoclonal mouse Sigma-Aldrich, St. Louis, MO 1:1000
Glial fibrillary acidic protein (GFAP) Polyclonal rabbit DAKO, Carpinteria, CA 1:1000
Glial fibrillary acidic protein (GFAP) Polyclonal chicken Covance, Berkeley, CA 1:500
Vimentin Monoclonal mouse DAKO 1:500
Nestin Monoclonal mouse Covance 1:500
Glutamine synthetase Monoclonal mouse MIllipore, San Diego, CA 1:1000
Glutamine synthetase Polyclonal rabbit Santa Cruz Biotechnology, Santa Cruz, CA 1:200
EAAT1 (GLAST) Monoclonal mouse Novocastra Lab, Newcastle upon Tyne, UK 1:100
EAAT2 (GLT-1) Polyclonal guinea-pig Millipore 1:1000
EAAT2 (GLT-1) Polyclonal rabbit Cell Signaling Technology, Inc, Boston, MA 1:100
S100 Polyclonal rabbit DAKO 1:400
CD44 Monoclonal mouse DAKO 1:80
CD44 Monoclonal rat Millipore 1:200
alphaB-Crystallin Polyclonal rabbit Stressgen, Canada 1:300
SPARC/Osteonectin Polyclonal goat R&D Systems, Inc., Minnezpolis, MN 1:200
SPARC/Osteonectin Polyclonal rabbit Cell Signaling 1:200
MAP2 Monoclonal mouse Sigma-Aldrich 1:250
Pan-neuronal neurofilament marker SMI 311 Monoclonal mouse Covance 1:1000
NeuN Monoclonal mouse Millipore 1:100
CD68 Monoclonal mouse DAKO 1:300
LN-3 Monoclonal mouse ICN Biomedicals, Inc., Aurora, OH 1:50
Iba-1 Polyclonal rabbit Biocare Madical, LLC, Concord, CA 1:500
Phospho-S6 ribosomal protein (Ser 235/236)* Monoclonal rabbit Cell Signaling 1:200
Phospho-S6 ribosomal protein (Ser 240/244)* Monoclonal rabbit Cell Signaling 1:200
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Monoclonal rabbit Cell Signaling 1:100
Tumor necrosis factor alpha (TNF alpha) Polyclonal goat Santa Cruz
Neurotropin receptor p75NTR Polyclonal rabbit Promega Corp.,Madison, WI 1:500
*- these two antibodies gave similar results.
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cent 6 images (1024 × 1024 pixel resolution, observed
area 606 × 606 μm) captured at a distance of 0.5 μm
from each other. Only cells with clearly outlined nuclei
were counted.
The size of a giant cells was quantified based on OD
of the area occupied by the cell body immunoreactive
for p-S6 and GS. In perituberal areas, the data on giant
cells in microtubers and giant cells located in normal
parenchyma were pooled together because we did not
find significant differences between these types of cells.
Images were obtained from stacks of 6 images (1024 ×
1024 pixel resolution, observed area 148 × 148 μm, step
0.5 μm). Only those cells that were unequivocally inden-
tified as giant cells (based on a large size, irregular shape,
and immunostaining) were taken into consideration.
To determine the level of GS, CD68 and Iba1 immu-
noreactivity, optical density (OD) was measured in the
area of interest (in microtubers, occupied with reactive
astrocytes with high levels of GFAP) in the imagesprepared as above (area of observation was 295 × 295 μm)
that were transferred to Adobe Photoshop, grayscaled
and used for analysis of OD with Scion Image Beta
4.02 (public domain). Level of EAAT2 immunoreactivity
was measured based on OD obtained from merged stacks
of adjacent 6 images (1024 × 1024 pixel resolution,
observed area 148 x 148 μm) captured at a distance of
0.25 μm from each other). EAAT2 and GFAP immunore-
activities correspond to different cellular compartments
(cytoplasm and plasma membrane, respectively) and the
surface occupied by GFAP and EAAT2 inversely correlate
(more cytoplasm in the area used for analysis of OD,
less plasma membranes). To determine the OD of EAAT2
we used an equation: ODEAAT2 = ODEAAT2/(SAOI −
ODGFAP −ODNissl), where SAOI stands for the area of
the image where OD was determined, ODGFAP and
ODNissl stand for area occupied with GFAP OD and
nuclei, respectively. Thus we have calculated arbitrary
units, that indicate the EAAT2 OD for arbitrary units
of plasma membrane.
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every area of interest (perituberal area, microtubers, tubers,
tuber borders) for quantification of cell number and OD.
Statistical analysis
Data are expressed as mean ± SEM. Differences in the
incidence were analyzed by Chi-square test. Continuous
parameters were analyzed with Student’s t-test or with
one- way ANOVA where appropriate. P < 0.05 was con-
sidered significant.
Results
Defining the borders of cortical tubers
To discriminate between perituberal cortex and tubers, it
is first critical to demarcate the cortical tubers themselvesFigure 1 Astrogliosis delineates the border of cortical tubers. (a-c) Hig
synthetase (GS) (b) outline tubers from surrounding normal tissue. Note un
(microtubers) nearby (arrows, marked only some). (d) Gliotic tuber astrocyt
Note: giant αB-Crystallin immunopositive cells (arrows) are present in tuber an
the main body (tuber) and gliotic protuberances (*) which make tuber borde
(high levels of GFAP) astrocytes are neatly segregated at a tuber border (dotte
(f1) (lower boxed area outlined in f) Only few protoplasmic astrocytes (arrow
tissue near the border. (f2) (upper boxed area outlined in f) Long processes o
protoplasmic astrocytes (arrows). (d-f) Confocal microcopy, double immunost
f images, respectively. In d and d’ only split images obtained from double-im
line. scale bars: 950 μm in a-c; 150 μm in d-f.in histological sections. Based on immunohistochemical
analysis, we have found that astrogliosis is the best criter-
ion for morphological discrimination between tubers and
the surrounding neocortical parenchyma (Figure 1). In
addition to providing a clear histological delineation of tu-
bers, this proposal is in line with MRI data where both
T1- and T2-weighted images correlate with the level of
tissue sclerosis/gliosis [13]. Several markers of astrocytes
were used to determine tuber astrogliosis and accordingly
tuber borders. These included markers typical for gray
matter protoplasmic astrocytes such as glutamine synthe-
tase (GS) and the astrocyte specific glutamate transporters
(EAAT1 and EAAT2), all of which showed profoundly
lower levels in tubers (Figure 1). In addition, markers that
are seen in reactive/gliotic astrocytes such as glial fibrillaryh levels of GFAP (a) and CD44 (c) and low levels of glutamine
dulated surface of the tubers and appearance of small gliotic foci
es reveal a profound decrease in EAAT2 and high levels of αB-Crystallin.
d in perituberal area. (e) A difference in the levels of GS and GFAP outline
r highly irregular in shape. (f) Protoplasmic (high levels of GS) and gliotic
d line). Note that giant cells (arrows) show high level of GS expression.
indicates one protoplasmic astrocyte) are located within the gliotic tuber
f tuber astrocytes penetrate into the perituberal area populated with
aining, counterstaining with Nissl. d’, e’, e”, and f’ represent split d, e, and
munostained sections are shown. Tuber border is depicted with dotted
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S100 revealed striking increases in tuber tissue (Figure 1,
only some shown). Tuber borders were thus clearly out-
lined, segregating perituberal protoplasmic astrocytes from
tuber gliosis (Figure 1). We observed that the borders of
tubers were not always smooth, displaying uneven profiles
with many peripheral protrusions (Figure 1a,b,c,e). Long
processes of tuber astrocytes penetrated into the peritub-
eral parenchyma and intermingled with neighboring proto-
plasmic astrocytes (Figure 1f). Furthermore, small foci of
astrogliosis (microtubers, see below) were regularly found
near the tuber borders (Figure 1a,b,c).
Tuber-specific cellular abnormalities in perituberal
MRI-normal tissue
Most of the observations presented in this section were
obtained from MRI-normal, epileptogenic perituberal
tissue (n = 10) that was dissected during surgery separ-
ately from tubers. Macroscopic tubers were never found
in these samples of tissue.
Microtubers are common pathological feature of
perituberal tissue
In contrast to the highly gliotic tubers, the perituberal
gray matter was populated mainly with protoplasmic as-
trocytes displaying high levels of GS and low levels of
GFAP (Figure 2a,b). To detect abnormal cells typical for
tubers within perituberal tissue, we used several markers
specific for neurons and glial cells and known to be in-
creased in giant cells and cytomegalic neurons [14,15],
as well as p-S6, to look for mTOR activation [16]. In
every section from every specimen of perituberal tissue,
we found aberrant cells characteristic of tubers: giant
cells, gliotic astrocytes, and cytomegalic neurons.
In the perituberal gray matter, giant cells were usually
surrounded by fibrous-like astrocytes with long pro-
cesses displaying high levels of GFAP and CD44. These
small astrogliotic islands were clearly outlined from the
neighboring normal parenchyma containing protoplas-
mic astrocytes (Figure 1a,b,c; 2). We previously desig-
nated these microscopic islands as “microtubers” [11], in
contrast to the canonical cortical “macrotubers” detected
by MRI. They were relatively homogeneous in size, with
an average diameter of 284.7 ± 17.3 μm (n = 70; range:
max 461.6 μm, min 158.6 μm). If we consider the shape
of microtubers as roughly spherical, we estimate that
one microtuber is composed, on average, of ~ 27 astro-
cytes and includes ~ 20 neurons.
Two types of microtubers were distinguished based on
the shapes and immune profile of astrocytes. The major-
ity (∼80%) of microtubers (which we designated as type I)
contained many astrocytes with long processes that ra-
diated for several hundred micrometers into the adja-
cent gray matter, which was occupied by protoplasmicastrocytes (Figure 2a,b,d). The processes of these cells
were devoid of the miniature lamellipodial-like pro-
cesses that are a characteristic feature of protoplasmic
astrocytes. Such structural feature was especially obvi-
ous when cells were immunostained for the plasma
membrane glycoprotein CD44 (Figure 2b1). A minority
(~20%) of microtubers (designated type II) were largely
composed of astrocytes with processes of normal length
endowed with many miniature lamellipodial leaf-like ex-
tensions that produced the typical bushy-like appearance
of protoplasmic astrocytes (Figure 2a,c). However, in con-
trast to typical protoplasmic astrocytes, these cells were
CD44+ (Figure 2c). It is worth noting that some type II
microtubers contained only a few (2–4 in a plane of
inspection) reactive-like astrocytes neighboring a giant
cell (Figure 2e).
We suggest that the astrocytes with long, non-branched
processes in type I microtubers are similar in many ways
to the CD44+ long-process/interlaminar astrocytes in gray
matter and/or to fibrous astrocytes in white matter,
whereas astrocytes with processes of protoplasmic astro-
cytes size and shape, but CD44+, in type II microtubers
are reactive protoplasmic astrocytes. To test this hypoth-
esis we used immunostaining for SPARC/osteonectin, a
glycoprotein we have found to be a characteristic marker
of CD44+ interlaminar and fibrous astrocytes in human
brain [17]. Indeed, type I microtubers contained many
SPARC+ astrocytes whereas only a few SPARC+ cells were
observed in type II microtubers (11.8 ± 0.824 per microtuber
in type I vs 0.824 ± 0.3 in type II, p < 0.001) (Figure 3a,b). In
addition, all SPARC+ astrocytes were CD44+ and had
clearly outlined, long main branches without lamellipodial-
like processes (Figure 3c). It should be noted that many
giant cells also showed immunolabelling for SPARC
(Figures 3b,d; 4c,d).
Astrocytes in both types of microtubers were character-
ized by diminished immunoreactivity for glutamate trans-
porters (EAAT2 and EAAT1) (only EAAT2 was quantified,
OD, arbitrary units, 0.1 ± 0.03 in microtubers vs 0.6 ± 0.3 in
surrounding normal parenchyma, p < 0.001) and for
GS (OD, arbitrary units, 1199.7 ± 296.6 in microtu-
bersvs 9874.4 ± 1321.8 in surrounding normal paren-
chyma, p < 0.001) (Figure 3e-g). This decrease in GS
and glutamate transporters was particularly prominent
in the central part of microtubers, where many neu-
rons were surrounded by astrocytes lacking these pro-
teins (Figure 3e-g).
Many astrocytes in microtubers showed p-S6 immunore-
activity (Figure 4a,c,d). Especially prominent p-S6 expression
was observed in microtubers located in deep cortical layers
(255 of 349 astrocytes in V-VI layers vs. 46 of 123 astro-
cytes in upper I-IV layers, p < 0.001).
To gain additional insight into the characteristics of astro-
cytes in microtubers, we tested activation (phosphorylation)
Figure 2 Microtubers in perituberal tissue. (a) Microtubers differ in the shape of astrocytes: type I (asterisk) has astrocytes with long processes,
whereas type II (star) has astrocytes with regular lengths of processes. Inset, enlarged boxed area outlined in (a), GS+ giant cell (arrow) in type II
microtuber. (b, c) Immunostaining for plasma membrane glycoprotein CD44 emphasizes the difference in the shapes of astrocytes in type I
(b) and type II (c) microtubers. Note that fibrous-like astrocytes in type I microtubers do not have small leaf-like processes and main
branches are clearly outlined (b1), in contrast CD44+ astrocytes in II type microtubers, display an abundance of miniature leaf-like processes
located on main branches, which produces the characteristic bushy-like view of the cell (c1). (d) Type I microtuber with vimentin (VIM)
immunoreactive giant cell (arrow). Note that astrocytes (arrowheads) with long process express VIM, a typical feature of reactive astrocytes. (e) Microtuber
composed of a p-S6+ giant cell (arrow) surrounded only by a few astrocytes with high levels of GFAP. Confocal microscopy, double immunostaining,
counterstaining with Nissl. a’, b’,b1’, c’, and c1’represent split images of a, b, b1, c, and c1, respectively. b1, c1, d1, and e1 –enlarged boxed area outlined in
b, c, d, and e respectively. scale bars: 150 μm in a; 55 μm in b,c, and d; 80 μm in e.
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activated in tubers [18]. We found that many astrocytes in
microtubers displayed a high level of p44 (Figure 4b,c).
Microtubers located in deep cortical layers and in white
matter contained more p44+ astrocytes than those in upper
gray matter layers (56 of 121 cells in upper layers vs. 156/
184 in deep layers, p < 0.001). Only a few (6/61) giant
cells revealed immunoreactivity for p44 (Figure 4c).
Many p44+ astrocytes were also immunopositive for p-
S6 (in deep cortical microtubers ~ 80%, 214 of 305 p44+
astrocytes) (Figure 4c). Many SPARC+ astrocytes were
also p-S6+ (Figure 4d).The appearance of reactive-like astrocytes in the im-
mediate vicinity of giant cells in microtubers raised the
possibility that giant cells might modulate their environ-
ment. We examined microtubers for microglial reaction
as a marker of inflammatory brain parenchymal distur-
bances. In 45/47 microtubers tested with CD68 and LN-
3 immunostaining, there was no prominent activation
of microglia detected (shown only CD68, Figure 5a).
Optical density of CD68 immunolabelling did not differ
in microtubers from surrounding normal parenchyma
(6150 ± 885 arbitrary units per 1 mm2 in microtubers
vs 6030 ± 799 in normal parenchyma, P = 0.922). In
Figure 3 Astrocyte properties in microtubers. (a) Type I microtuber contains many SPARC+/CD44+ astrocytes with long processes. (b) Astrocytes in
type II microtuber are SPARC-negative. Note SPARC+ giant cell (arrow) in b). (c) SPARC+/CD44+ long process astrocyte does not have miniature
lamellipodial-like processes. (d,d1) Type I microtuber in upper cortical layers with vimentin+/SPARC+ (double headed arrow) and SPARC+ (arrows) giant cells.
Note that astrocytes (arrowheads) near giant cells are SPARC+ and vimentin+. (d1) enlarged central part of microtuber in d). (e-g) Glutamate transporters
(both, EAAT1 and EAAT2) and GS are decreased in microtuber astrocytes. Note that the central parts of microtubers with many neurons (arrows) are depleted
of EAAT2 (e,e1), EAAT1 (f), and GS (g). Giant SPARC+ cell located in the central part of the microtuber near blood vessel is marked with double-headed
arrow (g). Isolated SPARC+/GS+ giant cell in the neighboring parenchyma is marked with arrowhead (g). Confocal microscopy, double immunostaining
(a-f), counterstaining with Nissl, triple immunostaining (g). a1–enlarged boxed area outlined in a. a’, b’, e’, e1’, f’, g’, andg”represent split images from
a, b, e, e1, f, and g, respectively. scale bars: 100 μm in a,b; 45 μm in c,d; 115 μm in e,f; 170 μm in g.
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served in large areas that included the microtubers but
extended far beyond their boundaries (not shown). We
also used immunostaining for Iba1, as a general marker
for both resting and activated microglia, and did not find
significant microglial changes in microtubers (Figure 5b).
Numbers of Iba1+ microglial cells did not differ signifi-
cantly from surrounding normal parenchyma (61.3 ± 7.66
cell per 1 mm2 in microtubers vs 55.5 ± 8.08 in normal
parenchyma, P = 0.62).
We assayed also whether giant cells contain tumor ne-
crosis factor alpha (TNFα), as shown previously [18].
TNFα is a cytokine that is responsible for induction ofreactive changes in astrocytes in variable brain path-
ologies [19]. We found that many giant cells were
TNFα+ (in microtubers 14 of 21 cells, in macrotubers
77/115, p = 0.722) (Figure 5c,d).
In perituberal tissue, in addition to giant cells in micro-
tubers, we also found scattered giant cells surrounded by
normal appearing protoplasmic astrocytes (Figure 5e,f,g).
There were <1/10th as many of these isolated giant cells in
comparison to giant cells within microtubers (24 versus
235 cells), and they were found predominantly in upper
(I – III) cortical layers (19 of 24).
Giant cells in the perituberal gray matter (both in
microtubers and isolated) never reached as large a size
Figure 4 Astrocytes in microtubers reveal activation (phosphorylation) of ribosomal protein S6 (S6) and p44/42 MAPK (p44). (a)
p-S6+ astrocytes (arrowheads, marked only some) in microtubers in cortical layer V. A giant p-S6+ cell is marked with an arrow. Note that
several microtubers are located near each other. (b,c) p44+ astrocytes (arrowheads) in microtubers detected with polyclonal (b, red) and
monoclonal (c, green) primary antibodies. Giant cell p–S6+ and p44+ is marked with an arrow. (d) Many SPARC+ fibrous astrocytes express
p-S6 (arrowheads). Giant p-S6+ /SPARC+ cell is marked with an arrow. Confocal microscopy, double immunostaining, counterstaining with
Nissl (a-c), triple immunostaining (d). a1, b1, c1, and d1–enlarged boxed area in a, b, c, and d, respectively. a1’, b1’, c1’,d1’ and d1”represent
split a1, b1, c1, and d1 images, respectively. scale bars: 150 μm.
Sosunov et al. Acta Neuropathologica Communications  (2015) 3:17 Page 8 of 15as those within tubers (374.3 ± 22.2 μm2 (n = 20) vs 888.9 ±
40.88 μm2 (n = 20), respectively, p < 0.001) and never had
as long and thick processes as giant cells in tubers (com-
pare those in Figure 5e-g with those in Figure 6a-c). We
also did not find giant cells immunopositive for p75 neuro-
trophin receptor (p75) in perituberal tissue although
p75+ giant cells were often observed in tubers (106/
178 in tubers vs. 0/34 in microtubers, p < 0.001) (Figure 6c).
Such differences in giant cells might indicate differentdevelopmental routes or different growth and ‘matur-
ation’ of giant cells.
An examination of a single TSC patient’s hippocampus
that had a normal MRI appearance but was resected as
part of the epileptogenic zone revealed microtubers and
cytomegalic neurons in Ammon’s horn (Figure 6d,e), as
well as in the hilus (not shown). This further supports
the idea that microtubers represent important parts of
epileptogenic zones apart from tubers.
Figure 5 Microglia and giants cells in micro- and macrotubers. (a,b) Microglia are not activated in microtubers, levels of CD68 (a) and Iba1
(b) immunoreactivity are not increased within microtubers. (c,d) Immunolabelling for tumor necrosis factor alpha (TNFα) in microtubers (c) and in
tubers (d). (c) I type microtuber located near the tuber (marked with a dashed line) with a giant cell (arrow in c1 and c1’) both GS+ (blue) and
TNFα + (red). (d) Many giant cells (arrows, marked only some) contain TNFα in the central part of the tuber. (e-g) Giant cells (arrows) in
perituberal area located within non-reactive protoplasmic astrocytes. Note that in e) giant cell (arrow) is located near microtuber (asterisk).
Confocal microscopy, double immunostaining (a,b,d-g) counterstaining with Nissl, triple immunostaining (c). a’, b’,d’,c1’,g’ represent split a, b,
d,c1,g images, respectively. c1 - enlarged boxed area outlined in c. scale bars: 100 μm in a-c,e-g; 75 μm in d.
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Analysis of specimens stained with the pan-neuronal
marker NeuN did not show any peculiar features of the
neuronal population (cellular density, cytoarchitecture,
aberrant cellular types) in microtubers (Figure 6f ).
Cytomegalic/dysplastic neurons similar to those char-
acteristically found in tubers were also consistently
found in perituberal gray matter. These cells were mor-
phologically identified as large cells with long processes
that were immunopositive for neuronal (neurofilaments
[NF], microtubule-associated proteins [MAP2], and NeuN)
markers and immunonegative for giant cell markers (GS,
vimentin, nestin) (Figure 6g,h). Many giant cells in peritub-
eral tissue and tubers were also positive for NF and/orMAP2 (Figure 6i,j, shown only NF). However, in contrast to
cytomegalic neurons, the NF+/MAP+ giant cells expressed
astrocyte-specific markers, e.g. GS and vimentin, had a
bizarre shape, and one or several, eccentrically-located
nuclei.
The majority of cytomegalic (67 of 73), as well as some
normal-shaped neurons, in perituberal tissue were p-S6
immunoreactive (Figure 6h). However, we did not consider
this staining property to be a reliable marker of a neuronal
abnormality, since many neurons in neocortical and hippo-
campal gray matter in samples of brains obtained from
temporal lobe epilepsy and other non-epilepsy sur-
geries revealed high levels of p-S6 immunoreactivity
(unpublished data).
Figure 6 Giant cells and cytomegalic neurons in tubers and microtubers. (a-c) Giant cells (arrows) in tubers have large size, irregular shape,
and long processes. Note in c) giant cell is immunopositive for p75. (d,e) Tuber-specific abnormalities in epileptogenic hippocampus in TSC. (d)
Microtuber (arrow) in CA1 subfield. d1 enlarged central part of the microtuber in d) with giant cell (arrow); (e) Cytomegalic neuron (arrow) in
CA1 subfield. (f) Laminar cytoarchitecture of the cortex visualized with NeuN immunostaining is not changed in the microtubers (marked with
asterisks and boxed area). f1) enlarged boxed area in f). (g) Cytomegalic neuron (arrow) visualized by immunostaining for neurofilaments (NF)
within normal appearing parenchyma populated with protoplasmic astrocytes. (h) Cytomegalic neuron immunopositive for p-S6. Note: level of
neurofilament immunostaining in cytomegalic neurons exceeds that in surrounding normal neurons (g,h). (i) Cytomegalic neurons (arrowheads)
located in the upper cortical layers in the tuber don’t express markers (vimentin [VIM] and alpha B Crystallin [Cryst]) of giant cells (arrows). (j) Giant
cells located in the tuber at a level of the white matter are immunopositive for neurofilaments (arrows). Confocal microscopy, double immunostaining
(a-h), counterstaining with Nissl, triple immunostaining (i,j). c’, d1’, f’, f1’, g’, h’, i’, and j1’ represent split c, d1, f, f1, g, h, i, and j1 images, respectively. scale
bars: 100 μm in a-e; 150 μm in f-h; 80 μm in i,j.
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were not a part of perituberal microtubers (found in
0/31 microtubers examined by double staining for
NF/MAP2 and GFAP). In addition, we did not ob-
serve single giant cells near cytomegalic neurons (12
giant cells and 14 cytomegalic neurons examined in
double immunostains for NF/MAP2 and p-S6). We
also did not detect any significant alterations in NG2
cells or oligodendrocytephenotypes in microtubers
(not shown), similar to our previous analysis of tu-
bers [20].Astrocyte heterogeneity in cortical tubers
As emphasized above, one of the most prominent fea-
tures of tubers was a high level of astrogliosis. In 7/16
tubers, severe astrogliosis completely occupied the tuber
gray matter (to pia surface) and almost every astrocyte
was devoid of GS and glutamate transporter (EAAT1
and EAAT2) immunoreactivity. In the other 9/16 tubers,
we found that upper cortical layers (usually layer 1 and 2)
were populated with protoplasmic astrocytes and many
microtubers were located near the tubers (Figure 1a,b,c).
Small “islands” of protoplasmic astrocytes were observed
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pattern due to intermingled gliotic and non-gliotic areas
(Figure 1e, 7a). Because we did not make 3-D reconstruc-
tions of the whole tubers we cannot rule out the idea that
these island-like areas of normal brain parenchyma were
not in reality deep invaginations of perituberal, normal
parenchyma.
Although most tubers were composed of a homoge-
neous population of gliotic astrocytes, in some areas
within tubers it was possible to discriminate groups of
astrocytes displaying higher levels of vimentin, p-S6, andFigure 7 Astrocyte heterogeneity in tubers. (a) Variability in the levels o
portion of a tuber. (b) Microtuber-like areas delineated with vimentin (VIM)
cells are indicated with arrows. (c,d) Astrocytes revealing features of reactiv
groups in the cenral parts of the tubers. (e-h) Unusual forms of astrocytes
gliotic tuber parenchyma expressing high levels of GS (red) and EAAT2 (gre
processes; 2) neighboring gliotic astrocytes (arrowheads, shown only so
straight processes and high level of GS does not show immunoreactivity
immunoreactivity is observed only in astrocyte (arrow) main branches. Note: n
(h) Astrocyte with long main branches devoid of EAAT2 immunoreactivity
protoplasmic astrocyte in normal gray matter. Note abundance of small
main cellular branches. Confocal microscopy double (a,c,e,g) and triple
double immunostaining. b’ and c’ represent split b and c images, respect
bar: 140 μm in a-d, 70 μm in e,f,h, 45 μm in g,i.p44 than neighboring gliotic astrocytes (Figure 7b,c,d).
These cells were grouped around giant cells and might
correspond to microtubers with astrocytes that did not
reach the “final stage of gliotic maturation” observed in
neighboring highly gliotic tuber astrocytes. The average
diameter of such groups was 329 ± 15.1 μm (n = 15;
range: max 459.3 μm, min 236.7 μm), overlapping exten-
sively with the dimensions of the perituberal microtu-
bers. Indeed, these groups within tubers exceeded the
average dimension of microtubers in the perituberal par-
enchyma by less than the size of one astrocyte domainf glutamine synthetase (GS, green) and GFAP (red) in the peripheral
immunostaining of astrocytes in a periphery of a tuber. VIM+ giants
e (high levels of VIM and expression of p44) are composed in small
in ‘transitional’ areas at the tuber borders. (e) Fibrous-like astrocyte in
en). Note: 1) main branches of the cell have only small spine-like
me) express minimal levels of GS and EAAT2. (f) Astrocyte with long
for SPARC (arrowhead in e1). Giant cell is marked with arrow. (g) EAAT1
eighboring astrocyte (double headed arrow) has minimal EAAT1 and GS.
in small leaf-like processes is SPARC immunonegative. (i) Normal
leaf-like processes almost completely filling the neuropile between
(d,f,h,i) immunostaining, counterstaining with Nissl in cases with
ively. e1, f1, and h1 enlarged boxed area in e, f, and g, respectively. scale
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cesses from neighboring cells [21]).
The phenotype of astrocytes located at the tuber
border zones was different from that of astrocytes in the
central part of the tubers, as well as from that of normal
protoplasmic astrocytes in the neighboring gray matter.
These ‘transitional’ areas, which we speculate represent
developing gliosis in tubers, were populated with astro-
cytes that had characteristic features consistent with on-
going astrocyte changes. 1) Only in these areas were
there unusual astrocytes with shapes of fibrous astro-
cytes (cells with long processes devoid of miniature leaf-
like protrusions) and yet with high levels of GS, EAAT1,
and EAAT2, which are characteristic features of proto-
plasmic astrocytes (Figure 7e-h). Taking into consider-
ation that the majority of these unusual astrocytes didFigure 8 Reactive features of astrocytes in the tubers. (a) p44+ gliotic
in the peripheral parts of the tuber and are segregated from GS+ protopla
expression are p44 immunopositive (arrowheads in a1’ and a1”). (b) p44 +
cell (double headed arrow) expresses p44 and p-S6. p-S6+ microglia (arrow
SPARC. Note that protoplasmic astrocytes are p44 and SPARC immunonega
level of p-S6 expression in protoplasmic SPARC immunonegative astrocyte
microscopy, double immunostaining (a,b), counterstaining with Nissl; tr
enlarged inserts in a and b, respectively. c’, c”, c”’, d’, d”, and d”’ respectively spnot show immunoreactivity for SPARC (Figure 7f,h), we
considered them to be astrocytes with mixed protoplas-
mic and fibrous features. 2) Many astrocytes in these
areas were immunopositive for phosphorylated p44
MAPK. These p44+ astrocytes showed minimal immuno-
reactivity for GS and glutamate transporters. (Figure 8a-c).
3) p-S6+ astrocytes predominated in these areas and often
immunoreactivity for p-S6 colocalized with p44 and
SPARC (Figure 8b,d). Both p44+ and p-S6+ astrocytes
expressed SPARC and revealed low levels of GS and glu-
tamate transporters, whereas astrocytes with high levels of
GS and glutamate transporters were SPARC immunone-
gative (Figure 7f,h; 8c,d). Thus, many astrocytes in these
“transition zones” display features of both protoplasmic
and long-process astrocytes. These may well reflect a
phenotype in transition.astrocytes delineate the border between gliotic and non-gliotic areas
smic astrocytes. Note that only astrocytes with low levels of GS
astrocytes in transitional border area express p-S6 (arrowheads). Giant
) don’t show p44 immunoreactivity. (c) p44+ gliotic astrocytes express
tive (arrowheads). (d) SPARC+ astrocytes express p-S6. Note that the
s (arrowheads) is less than in SPARC+ astrocytes. Confocal
iple immunostaining (c,d). a1’, a1”, b1’, and b1”split images from
lit c and d images, respectively. Scale bar: 100 μm in a, 75 μm in b, c, d.
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reactivity for CD68 and Iba1) in these transitional areas
was similar to that in tubers and significantly exceeded
that of the non-gliotic areas surrounding tubers (not
shown).
Discussion
The consistent presence of tuber-specific abnormalities
in epileptogenic MRI-normal perituberal cortex and sub-
cortical white matter favors the thesis that brain path-
ology in TSC is much more widespread than is usually
considered and includes other forms of pathological al-
terations besides the classical entities of cortical tubers,
subependymal nodules, and giant cell astrocytomas [22-25].
Recent analysis of autopsied patients with TSC showed that
small groups of giant cells and neurons, named ‘microtu-
bers’, were found all over the neocortex and even in
cerebellum [12,26]. Our definition of ‘microtuber’ is
quite different because we include aberrant astrocytes
as essential components of microtubers. Thus we have
excluded isolated giant cells not surrounded with aberrant
astrocytes from this definition. Widespread perituberal
micropathology of clusters of giant cells and dysplastic
neurons was also reported recently in a series of surgi-
cally resected TSC tissues [27]. These pathological alter-
ations in the human brain in TSC resemble “diffuse”
changes involving the whole brain observed in animal
models of TSC [28-32] and thus may diminish critiques of
these models based on the absence of prominent focal loci
of aberrant brain architecture.
Is perituberal tissue an epileptogenic area?
What is the functional significance of aberrant cellular
elements in perituberal tissue? Do they participate in
seizure initiation and/or progression? Seizure origin in
TSC is the subject of much debate with several observa-
tions favoring perituberal tissue as a source of spontan-
eous epileptiform activity [5-9]. We found that perituberal
tissue contains both microtubers and cytomegalic neu-
rons, both of which may contribute to the epileptogenicity
of this tissue. Electrophysiological analysis of tubers and
cortical dysplasia has shown that only cytomegalic/dys-
plastic neurons revealed features of hyperexcitabilty, while
giant/balloon cells were electrophysiologically silent [33].
Cytomegalic neurons in perituberal tissue may have simi-
lar or identical properties of their tuber counterparts and
thus could potentially trigger ictal events. Similarly, the
aberrant astrocytes that surround giant cells in “microtu-
bers” are characterized by markedly diminished expression
of EAAT1, EAAT2, and GS, proteins important for the
uptake and metabolic conversion of glutamate to glutam-
ine within astrocytes. We have found that similar astro-
cytes in tubers have deficient glutamate uptake [34]. Thus,
even normal neurons located in microtubers may bepredisposed to overexcitation because of the profound
diminution of astrocytic glutamate clearance [35,36].
Our finding of microtubers and cytomegalic neurons
in an epileptogenic hippocampal focus (Figure 6) also
supports the thesis that these aberrant perituberal
components might be the triggers of perituberal sei-
zures in TSC.
Microtubers and the derivation of tuber gliotic astrocytes
Despite great progress in the molecular biology of TSC,
less is known about the origin and development of
phenotypic features of abnormal cell types in the TSC
brain. Analysis of microtubers may help to elucidate
how tuber gliotic astrocytes develop.
Cortical tubers are composed of tightly packed gliotic
astrocytes that make immunohistochemical analysis of
individual cell shape and properties very complicated, if
possible at all. In contrast, in microtubers where cells
are not so densely packed, we identified two types of as-
trocytes: 1) astrocytes with long, straight, main processes
lacking miniature leaf-like protrusions (the majority of
astrocytes) and 2) protoplasmic astrocytes revealing features
of reactive cells (a minority of cells). The first, based on
morphology and immune profile, are similar to the CD44+
long-process astrocytes found at the pial surface and in
white matter [17,21]. We propose that the majority of gliotic
tuber astrocytes are aberrant CD44+ long process/fibrous-
like astrocytes that due to abnormal development appear
and replace the normal protoplasmic astrocytes in gray mat-
ter. Thus, due to such aberrant development, astrocytes that
usually are located in white matter and the pial surface
populate the gray matter.
Although long-process astrocytes in normal gray mat-
ter were described by Ramon y Cajal [37], their appear-
ance and functions in gray matter remain mysterious. It
should be remarked that while the divergent develop-
ment of neurons and glial cells (including astrocytes) is well
studied [38,39], there is little known about the divergent ori-
gins of protoplasmic, CD44+ long process, and fibrous
astrocytes.
The appearance of reactive-like astrocytes in microtu-
bers raises critical questions about the relationship be-
tween giant cells and neighboring astrocytes. Why are
giant cells often but not always surrounded by reactive
protoplasmic astrocytes? What may be the cause of
these reactive-like changes in astrocytes? One possibility
based on our data is that giant cells may release cyto-
kines, e.g. TNFα that promote local reactive changes in
astrocytes. As is well known, TNFα is a powerful trigger
of reactive changes in astrocytes [19].
Many astrocytes in microtubers and in tubers showed
a high level of immunoreactivity for activated (phosphor-
ylated) p44 MAPK. It should be noted that overactiva-
tion of p44 was consistently observed and considered as
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related neoplasms [40]. p44 and mTOR pathways have
close, although not completely understood, interrelations.
p44 may inactivate the TSC1-TSC2 complex through
phosphorylation of TSC2 [41]; while mTOR can provide
negative (through p70 S6K1 and PI3K, [42]) or positive
(through protein phosphatase 2A, [43]) feedback on p44.
At this time, it remains unclear how p44 MAPK activation
may be related to astrocyte changes in TSC.
The heterogeneity of the astrocyte population in
microtubers and tubers shown in this study is in line
with a recent detailed analysis of the glial and neur-
onal populations in tubers [15]. These authors and
our previous work [20] defined several types of aber-
rant astrocytes in tubers, including reactive astrocytes.
Reactive changes in astrocytes, e.g. expression of p-S6
and p44, can be used as a good indicator of acute ongoing
cellular alterations [19,44].Are macrotubers built of microtubers?
Should microtubers be considered as elementary units
or domains, which by consecutive aggregation create the
main bodies of macrotubers? This “elementary unit”
hypothesis is grounded largely on the anatomical ob-
servations: 1) rather homogeneous size of microtubers; 2)
consistent association of microtubers with tuber borders;
3) appearance of microtuber-like areas with reactive astro-
cytes surrounding giant cells in tubers especially near their
borders. We hypothesize that the CD44+ long-process as-
trocytes and the giant cells in individual microtubers com-
prise the progeny of one or more neural precursors in the
embryonic ventricular zone (VZ) that have developed
LOH at a TSC locus or have developed another mutation
that interfere with their normal developmental program.
VZ cells that remain heterozygous at the TSC 1 or 2 loci
will generate normal cortical populations. Early genetic
changes that give rise to large numbers of altered VZ cells
may give rise to tubers, whereas late genetic changes,
which give rise to one or only a few altered VZ cells may
give rise to microtubers.Conclusion
In this study we have focused on astrocyte changes at
the perituberal border and in microtubers. This focus
has allowed us to define tuber borders. It has also
allowed us to define microtubers as units composed not
only of giant cells but also of aberrant gliotic astrocytes
which constitute and define features of macrotubers,
e.g. hardness of the tubers. Such an approach provides
novel insights into the cellular abnormalities in MRI
normal epileptogenic perituberal tissue in TSC, and
opens new perspectives to consider in the therapeutic
and surgical treatment of TSC related epilepsy.Competing interests
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